إعلان
إعلان
TXG
10x Genomics, Inc. Class A Common Stock
20.47
USDبرعاية
+1.18
+6.14%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
20.70
+0.23
+1.10%
تقارير أرباح TXG
النسبة الإيجابية المفاجئة
TXG تفوق 13 من 25 آخر التقديرات.
52%
التقرير التالي
الاسبوع القادم
بيانات التقرير القادم
١٢ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$157.54M
/-$0.22
التغير الضمني من Q3 25 (Revenue/ EPS)
+5.73%
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
-4.54%
/-45.00%
10x Genomics, Inc. Class A Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, TXG reported earnings of -0.22 USD per share (EPS) for Q3 25, beating the estimate of -0.29 USD, resulting in a 24.40% surprise. Revenue reached 149.00 مليون, compared to an expected 143.91 مليون, with a 3.54% difference. The market reacted with a +17.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 المحللين forecast an EPS of -0.22 USD, with revenue projected to reach 157.54 مليون USD, implying an زيادة of 0.00% EPS, and زيادة of 5.73% in Revenue from the last quarter.
الأسئلة الشائعة
What were 10x Genomics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, 10x Genomics, Inc. Class A Common Stock reported EPS of -$0.22, beating estimates by 24.4%, and revenue of $149.00M, 3.54% above expectations.
How did the market react to 10x Genomics, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved up 17.31%, changed from $13.00 before the earnings release to $15.25 the day after.
When is 10x Genomics, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for ١٢ يناير ٢٠٢٦.
What are the forecasts for 10x Genomics, Inc. Class A Common Stock's next earnings report?
Based on 18
المحللين, 10x Genomics, Inc. Class A Common Stock is expected to report EPS of -$0.22 and revenue of $157.54M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان